Is there any relation between insulin resistance and cognitive function in the elderly?

International Psychogeriatrics

Volumn 19, Issue 4, 2007, Pages 745-756

  Isik, Ahmet Turan ^a   Cankurtaran, Mustafa ^a   Bozoglu, Ergun ^a   Comert, Bilgin ^a   Doruk, Huseyin ^a   Mas, Mehmet Refik ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cognitive status; Dementia; Elderly; Insulin resistance

Indexed keywords

AGED; ALZHEIMER DISEASE; AMPLIFIED RIBOSOMAL DNA RESTRICTION ANALYSIS; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; EVALUATION; FEMALE; GERIATRIC HOSPITAL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; OUTPATIENT; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

AGED; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 34447128849     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610207005406     Document Type: Article

References (30)

1. Abbatecola, A. M. et al. (2004). Insulin resistance and executive dysfunction in older persons. Journal of the American Geriatrics Society, 52, 1713-1718.
2. Alarcon de la Lastra, C., Sanchez-Fidalgo, S., Villegas, I. and Motilva, V. (2004). New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists. Current Pharmaceutical Design, 10, 3505-3524.
3. Alexander, C. M., Landsman, P. B., Teutsch, S. M. and Haffner, S. M.; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). (2003). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes, 52, 1210-1214.
4. Bhat, R. V., Budd Haeberlein, S. L. and Avila, J. (2004). Glycogen synthase kinase 3: a drug target for CNS therapies. Journal of Neurochemistry, 89, 1313-1317.
5. Craft, S. et al. (2003). Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease interactions with apolipoprotein E genotype. Psychoneuroendocrinology, 28, 809-822.
6. Gasparini, L., Netzer, W. J., Greengard, P. and Xu, H. (2002). Does insulin dysfunction play a role in Alzheimer's disease? Trends in Pharmacological Sciences, 23, 288-293.
7. Gauthier, S. G. (2005). Alzheimer's disease: the benefits of early treatment. European Journal of Neurology, 12 (Suppl. 3), 1-16.
8. Gokcel, A. et al. (2003). Detection of insulin resistance in Turkish adults: a hospital-based study. Diabetes, Obesity and Metabolism, 5, 126-130.
9. Gold, G. et al. (1997). Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology, 49, 690-694.
10. Hachinski, V. C. et al. (1975). Cerebral blood flow in dementia. Archives of Neurology, 32: 632-637.
11. Ho, L. et al. (2004). Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. The FASEB Journal, 18, 902-904.
12. Hoyer, S. (1998). Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. Journal of Neural Transmission, 105, 415-422.
13. Kanauchi, M., Yamano, S., Kanauchi, K. and Saito, Y. (2003). Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. Journal of Clinical Endocrinology and Metabolism, 88, 3444-3446.
14. Kudo, T. et al. (2000). Are cerebrovascular risk factors involved in Alzheimer's disease? Neurobiology of Aging, 21, 215-224.
15. Liolitsa, D., Powell, J. and Lovestone, S. (2002). Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 73, 261-266.
16. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
17. Munshi, M. et al. (2006). Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care, 29, 1794-1799.
18. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303-308. Erratum in Archives of Neurology, 56, 760.
19. Pilcher, H. (2006). Alzheimer's disease could be "type 3 diabetes". Lancet Neurology, 5, 388-389.
20. Rasgon, N. and Jarvik, L. (2004). Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 59,178-183; discussion 184-192.
21. Rasgon, N. L. and Kenna, H. A. (2005). Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis. Neurobiology of Aging, 26, 103-107.
22. Razay, G. and Wilcock, G. K. (1994). Hyperinsulinaemia and Alzheimer's disease. Age and Ageing, 23, 396-399.
23. Samuels, S. C. and Grossman, H. (2003). Emerging therapeutics for Alzheimer's disease: an avenue of hope. CNS Spectrums, 8, 834-845.
24. Smith, C. D., Wekstein, D. R., Markesbery, W. R. and Frye, C. A. (2006). 3alpha,5alpha-THP: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia. Psychopharmacology (Berlin), 186, 481-485.
25. Stolk, R. P. et al. (1997). Insulin and cognitive function in elderly population: the Rotterdam Study. Diabetes Care, 20, 792-795.
26. Strachan, M. W. (2003). Insulin and cognitive function. Lancet, 362, 1253.
27. Taubes, G. (2003). Neuroscience:insulin insults may spur Alzheimer's disease. Science, 301, 40-41.
28. Watson, G. S. and Craft, S. (2003). The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs, 17, 27-45.
29. Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., Van Bronswijk, W. and Martins, R. (2002). Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. Journal of Neuroscience, 22, RC221.
30. Yaffe, K. et al. (2004). The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA, 292, 2237-2242.